Who is sponsoring NCT05126355?

NCT05126355 is sponsored by University of Pittsburgh.

What drugs are being tested in NCT05126355?

Interventions in NCT05126355: On the Move group exercise.

What condition does NCT05126355 study?

NCT05126355 studies Mobility Limitation.

Is NCT05126355 still recruiting?

NCT05126355 is currently active, enrolled. Last updated 6 November 2025.

Last reviewed 2025-11-06 · How we verify

NCT05126355

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of the On the Move Group Exercise Program to Improve Mobility in Community-dwelling Older Adults

Active, enrolled NA Last updated 6 November 2025

What this trial tests

NA trial testing On the Move group exercise in Mobility Limitation in 529 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

23 June 2022

Primary endpoint
18 September 2025

31 August 2026

Quick facts

Lead sponsor	University of Pittsburgh
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	529
Start date	23 June 2022
Primary completion	18 September 2025
Estimated completion	31 August 2026
Sites	1 location across United States

Drugs / interventions tested

On the Move group exercise

Conditions studied

Mobility Limitation — all drugs for Mobility Limitation →

Sponsor

University of Pittsburgh

Who can join

60 and older, any sex, with Mobility Limitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to test the effectiveness of On the Move (OTM) in terms of improving mobility among 502 older adults in 44 senior community centers and to evaluate intervention fidelity, including adherence and competence, and the impact of organizational, instructor, and participant level factors on intervention fidelity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

On the Move in the community: Protocol for a hybrid 1 trial examining effectiveness and fidelity of a community-based group exercise program for older adults.
Brach JS, VanSwearingen JM, Freburger J, Weiner BJ, et al · · 2024 · cited 1× · PMID 39159805 · DOI 10.1016/j.cct.2024.107666

Verify or expand the search:

Other recruiting trials for Mobility Limitation

Currently open trials in the same condition.

NCT07125378 — Living Independence Through Functional Training · Phase 1, PHASE2 · recruiting
NCT07174973 — Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis · NA · recruiting
NCT07308353 — Comparative Effects Of Exergaming And Otago Exercise On Anticipatory Postural Control And Sensory Integration In Older A · NA · active not recruiting
NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
NCT06592144 — TESTO-TRIAL: Use of Testosterone in Critically Ill Patients · Phase 4 · active not recruiting

Other University of Pittsburgh trials

Trials by the same sponsor.

NCT05601206 — Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE · NA · not yet recruiting
NCT06652815 — Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation · not yet recruiting
NCT06474286 — Prucalopride for Cognitive Functioning in Schizophrenia · NA · not yet recruiting
NCT06488469 — Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus · NA · not yet recruiting
NCT06652802 — Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05126355 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pittsburgh
Last refreshed: 6 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05126355.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing